Edge Therapeutics’ Chief Executive Officer Brian Leuthner Receives EY Entrepreneur Of The Year™ 2015 New Jersey Region Award

June 26, 2015

BERKELEY HEIGHTS, N.J.–(BUSINESS WIRE)–Edge Therapeutics, Inc. today announced that Brian A. Leuthner, the company’s Chief Executive Officer, President, and Co-founder, has received the EY Entrepreneur Of The Year™ 2015 New Jersey Region Award in the “Pharmaceutical & Diagnostic Private Companies” category. He was selected by an independent judging panel comprising previous winners of the award, leading CEOs, private capital investors and other regional business leaders. Mr. Leuthner’s award, along with New Jersey Region Award winners in several other categories, were announced at a special gala on June 25 at the Hyatt Regency New Brunswick.

According to EY, a global leader in assurance, tax, transaction and advisory services, and a division of Ernst & Young LLP, the EY Entrepreneur Of The Year award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

As a New Jersey Region award winner, Mr. Leuthner is now eligible for consideration for the EY Entrepreneur Of The Year 2015 National Award. Award winners in several national categories, as well as the overall EY Entrepreneur Of The Year National Award winner, will be announced at the national awards gala in Palm Springs, Calif., in November 2015. The awards are the culminating event of the EY Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.

Mr. Leuthner co-founded Edge along with R. Loch Macdonald, the company’s Chief Scientific Officer, and Carl J. Soranno in 2009. Mr. Leuthner also serves on the company’s board of directors and has more than 25 years of experience in the hospital acute care marketplace, with a specific expertise in critical care and neurocritical care.

Prior to founding Edge, Mr. Leuthner was the CEO of Fontus Pharmaceuticals, the Senior Head of Marketing for The Medicines Company and the Director of Market Development for ESP Pharma. He also held marketing and sales positions of significant responsibility at Burroughs Wellcome, GlaxoWellcome and Ortho Biotech. In these leadership roles, he helped create and advance hospital business units, develop and launch new critical care products and strengthen customer relationships.

Mr. Leuthner received his B.S. and M.B.A. degrees from the University of North Carolina at Chapel Hill.

About EY Entrepreneur Of The Year®

EY Entrepreneur Of The Year® is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 140 cities in more than 50 countries.

About Edge Therapeutics

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, our lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, our second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain.

Contacts

Investors:
Edge Therapeutics, Inc.
Allison Wey, 1-800-208-EDGE (3343)
awey@edgetherapeutics.com